Viridian Therapeutics, Inc. VRDN Total Operating Expenses
Total Operating Expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s total operating expenses?
- Viridian Therapeutics, Inc. (VRDN) reported total operating expenses of $116.31M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Viridian Therapeutics, Inc.'s total operating expenses increased by 23.8% year-over-year, from $93.94M to $116.31M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s total operating expenses has grown at a 51.4% compound annual growth rate (CAGR), from $82.69M to $434.24M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.